- Accesswire•13 days agoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Misonix, Inc. - MSON
NEW YORK, NY / ACCESSWIRE / January 4, 2017 / Levi & Korsinsky announces it has commenced an investigation of Misonix, Inc. (NASDAQ: MSON) concerning possible breaches of fiduciary duty by the board of ...
- PR Newswire•29 days ago
FARMINGDALE, N.Y., Dec. 19, 2016 /PRNewswire/ -- Misonix, Inc. (MSON), a leading provider of ultrasonic surgical tools, announced today the appointment of Stavros G. Vizirgianakis as the Company's President and Chief Executive Officer effective immediately. Mr. Vizirgianakis has served as interim Chief Executive Officer since September 2, 2016, and has served as a member of the Misonix Board of Directors since May 2013. Separately, the Company announced the resignation of T. Guy Minetti from the Board of Directors after leading the Board process to recruit Mr. Vizirgianakis to accept the CEO role.
- PR Newswire•2 months ago
FARMINGDALE, N.Y., Nov. 28, 2016 /PRNewswire/ -- Misonix, Inc. (MSON) ("Misonix" or the "Company"), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic surgery and other surgical applications, announced that The Nasdaq Stock Market LLC ("Nasdaq") has accepted the Company's plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) which would permit the continued listing of Misonix common stock on the Nasdaq Global Market.
MSON : Summary for MISONIX, Inc. - Yahoo Finance
Misonix, Inc. (MSON)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||10.50 x 1000|
|Ask||11.50 x 500|
|Day's Range||10.65 - 11.15|
|52 Week Range||3.83 - 11.20|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||27.68|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|